Nicholaus E. Johnson

Associate
Full contact info

From formation to exit, Nicholaus strategically resolves legal and practical matters with individualized attention resulting in satisfied firm clients.

Experience

Mirum Pharmaceuticals – $275 Million Convertible Senior Notes Offering

April 13, 2023

Cooley advised Mirum Pharmaceuticals on its $275 million aggregate principal amount of 4.00% convertible senior notes due 2029. Mirum is a biopharmaceutical company dedicated to transforming the treatment of rare liver diseases. Jason Kent and Jason Savich led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Jason Savich
Partner, San Francisco
Daniel Gillon
Associate, San Diego
Stevie Yu
Associate, New York
Marjorie Roesser
Associate, San Francisco
Nicholaus E. Johnson
Associate, San Diego
Winda Fung
Associate, Los Angeles Santa Monica

Related Practices & Industries

Mirum Pharmaceuticals – $92 Million Follow-on Offering

September 7, 2022

Cooley advised the issuer for Mirum Pharmaceuticals’ $92 million follow-on offering of 4,000,000 shares of common stock at a public offering price of $23 per share. Mirum is a biopharmaceutical company developing and commercializing therapies for rare and debilitating liver diseases. Partner Jason Kent led the Cooley team.

Related contacts

Jason Kent
Partner, New York
Nicholaus E. Johnson
Associate, San Diego
Daniel Gillon
Associate, San Diego
Barbara Mirza
Partner, Los Angeles Santa Monica
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Vuori Secures $400 Million Investment From SoftBank Vision Fund 2

November 3, 2021

Cooley advised Vuori on its $400 million investment from SoftBank Vision Fund 2 at a valuation of $4 billion, marking one of the largest investments in a private apparel company. Vuori merges technical clothing with a West Coast aesthetic that looks and feels great. As Vuori embarks upon its next phase of growth,  it will continue to expand its product offerings, make key investments in infrastructure and people, and expand boost its sustainability efforts.

Related contacts

Megan Browdie
Partner, Washington, DC
Nicholaus E. Johnson
Associate, San Diego
Jason Kent
Partner, New York
Richard G.S. Lee
Associate, Washington, DC
Kyrsten Lundh
Associate, San Diego
Amanda Pacheco
Associate, Palo Alto
Jeffrey J. Tolin
Partner, New York
Jessica Wade
Paralegal Specialist, San Diego

Related Practices & Industries

Prothena Agrees to Sell ATTR Amyloidosis Program to Novo Nordisk

July 27, 2021

Cooley advised Prothena, a late-stage clinical company with a robust pipeline of novel investigational therapeutics, on its agreement to sell its clinical-stage antibody PRX004 and broader amyloid transthyretin (ATTR) amyloidosis program to Novo Nordisk for $1.2 billion. Partners Marya Postner and Barbara Borden led the Cooley team advising Prothena.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Barbara Borden
Partner, San Diego
Rowook Park
Partner, San Diego
Nicholaus E. Johnson
Associate, San Diego
Carly Robinson
Associate, Reston

Related Practices & Industries

Memberships & affiliations

American Bar Association

California Lawyers Association, Business Law and Tax Sections